UroGen Pharma Ltd (URGN)
13.16
-0.15
(-1.13%)
USD |
NASDAQ |
May 23, 12:25
UroGen Pharma Shareholders Equity (Quarterly): -40.13M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -40.13M |
| December 31, 2023 | -65.21M |
| September 30, 2023 | -41.99M |
| June 30, 2023 | -138.43M |
| March 31, 2023 | -116.55M |
| December 31, 2022 | -89.36M |
| September 30, 2022 | -63.29M |
| June 30, 2022 | -40.91M |
| March 31, 2022 | -17.07M |
| December 31, 2021 | 8.413M |
| September 30, 2021 | 31.54M |
| June 30, 2021 | 56.27M |
| March 31, 2021 | 76.49M |
| December 31, 2020 | 96.36M |
| September 30, 2020 | 120.53M |
| Date | Value |
|---|---|
| June 30, 2020 | 142.66M |
| March 31, 2020 | 150.45M |
| December 31, 2019 | 180.30M |
| September 30, 2019 | 210.92M |
| June 30, 2019 | 224.78M |
| March 31, 2019 | 239.59M |
| December 31, 2018 | 90.09M |
| September 30, 2018 | 103.58M |
| June 30, 2018 | 113.55M |
| March 31, 2018 | 123.87M |
| December 31, 2017 | 68.52M |
| September 30, 2017 | 76.26M |
| June 30, 2017 | 74.07M |
| December 31, 2016 | 16.31M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-138.43M
Minimum
Jun 2023
224.78M
Maximum
Jun 2019
34.29M
Average
19.98M
Median
Shareholders Equity (Quarterly) Benchmarks
| Agenus Inc | -201.43M |
| Exelixis Inc | 2.128B |
| Geron Corp | 344.87M |
| Protalix BioTherapeutics Inc | 29.79M |
| InfuSystems Holdings Inc | 52.28M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 200.57M |
| Total Liabilities (Quarterly) | 240.71M |
| Debt to Equity Ratio | -2.432 |
| Current Ratio | 7.47 |
| Net Debt Paydown Yield | -0.00% |